Feasibility of Staged Bilateral Radiofrequency Ventral Intermediate Nucleus Thalamotomy for Bilateral Essential Tremor.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
05 2019
Historique:
received: 22 08 2018
revised: 30 01 2019
accepted: 31 01 2019
pubmed: 17 2 2019
medline: 4 1 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

Patients with bilateral and/or midline/axial tremor have significant diminution in quality of life (QOL). Various studies report high complication rates with bilateral thalamotomy. However, use of primitive methods in these studies confers questionable validity. We conducted a retrospective observational cohort study in patients with medication-refractory bilateral essential tremor treated with staged bilateral radiofrequency ventral intermediate nucleus thalamotomy to subjectively examine the impact of any adverse effects on QOL and patient satisfaction. Eight patients who had undergone staged bilateral radiofrequency ventral intermediate nucleus thalamotomy were included and completed a customized questionnaire. Patients returned the completed questionnaire by mail for statistical analysis. All 8 patients had improved QOL. Seven patients were satisfied with the received treatment, although residual neck and hand tremor remained in 5 and 4 patients, respectively. None of the patients reported worsening of symptoms or severe disability in any area. Adverse effects included speech difficulty, difficulty in concentration, memory loss, and calculation difficulty. All 8 patients were self-reliant in doing everyday tasks that were not possible before the treatment suggesting the nondisabling nature of the adverse effects that occurred. Adverse effects that are nondisabling and hence acceptable to the patient can be considered acceptable adverse effects. Staged bilateral radiofrequency ventral intermediate nucleus thalamotomy definitely improves QOL in patients with medication-refractory bilateral essential tremor despite occurrence of acceptable adverse effects.

Sections du résumé

BACKGROUND
Patients with bilateral and/or midline/axial tremor have significant diminution in quality of life (QOL). Various studies report high complication rates with bilateral thalamotomy. However, use of primitive methods in these studies confers questionable validity. We conducted a retrospective observational cohort study in patients with medication-refractory bilateral essential tremor treated with staged bilateral radiofrequency ventral intermediate nucleus thalamotomy to subjectively examine the impact of any adverse effects on QOL and patient satisfaction.
METHODS
Eight patients who had undergone staged bilateral radiofrequency ventral intermediate nucleus thalamotomy were included and completed a customized questionnaire. Patients returned the completed questionnaire by mail for statistical analysis.
RESULTS
All 8 patients had improved QOL. Seven patients were satisfied with the received treatment, although residual neck and hand tremor remained in 5 and 4 patients, respectively. None of the patients reported worsening of symptoms or severe disability in any area. Adverse effects included speech difficulty, difficulty in concentration, memory loss, and calculation difficulty. All 8 patients were self-reliant in doing everyday tasks that were not possible before the treatment suggesting the nondisabling nature of the adverse effects that occurred.
CONCLUSIONS
Adverse effects that are nondisabling and hence acceptable to the patient can be considered acceptable adverse effects. Staged bilateral radiofrequency ventral intermediate nucleus thalamotomy definitely improves QOL in patients with medication-refractory bilateral essential tremor despite occurrence of acceptable adverse effects.

Identifiants

pubmed: 30771542
pii: S1878-8750(19)30336-5
doi: 10.1016/j.wneu.2019.01.224
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e992-e997

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ghate Prajakta (G)

Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.

Shiro Horisawa (S)

Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.

Takakazu Kawamata (T)

Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.

Takaomi Taira (T)

Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan. Electronic address: ttaira@twmu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH